Literature DB >> 29936336

Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.

Stefanie Nicole Hayer1, Yvonne Schelling2, Jeannette Huebener-Schmid3, Jonasz Jeremiasz Weber3, Stefan Hauser1, Ludger Schöls4.   

Abstract

A skin biopsy of a patient with spinocerebellar ataxia type 3 (SCA3, also known as Machado-Joseph disease (MJD)) caused by a CAG trinucleotide repeat expansion in the ATXN3 gene, was used to generate an induced pluripotent stem cell line, HIHCNi002-A (iPSC-SCA3). Skin fibroblasts were reprogrammed using episomal plasmids carrying hOCT4, hSOX2, hKLF4, hL-MYC, and hLIN28. The iPSC-SCA3 line exhibits chromosomal stability with conservation of the ATXN3 repeat expansion, expresses pluripotency markers and differentiates into endo-, meso-, and ectodermal cells in vitro.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29936336     DOI: 10.1016/j.scr.2018.06.006

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  8 in total

1.  Pathophysiological interplay between O-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3.

Authors:  Priscila Pereira Sena; Jonasz J Weber; Maxinne Watchon; Katherine J Robinson; Zinah Wassouf; Stefan Hauser; Jacob Helm; Mahkameh Abeditashi; Jana Schmidt; Jeannette Hübener-Schmid; Ludger Schöls; Angela S Laird; Olaf Riess; Thorsten Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

2.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

3.  Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

4.  Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons.

Authors:  Stefan Hauser; Jacob Helm; Melanie Kraft; Milena Korneck; Jeannette Hübener-Schmid; Ludger Schöls
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

5.  KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP.

Authors:  Jonasz Jeremiasz Weber; Priscila Pereira Sena; Mahkameh Abeditashi; Ana Velic; Maria Kalimeri; Rana Dilara Incebacak Eltemur; Jana Schmidt; Jeannette Hübener-Schmid; Stefan Hauser; Boris Macek; Olaf Riess; Thorsten Schmidt
Journal:  Cell Mol Life Sci       Date:  2022-07-06       Impact factor: 9.207

6.  Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3.

Authors:  Tina Harmuth; Caroline Prell-Schicker; Jonasz J Weber; Frank Gellerich; Claudia Funke; Stefan Drießen; Janine C D Magg; Guido Krebiehl; Hartwig Wolburg; Stefanie N Hayer; Stefan Hauser; Rejko Krüger; Ludger Schöls; Olaf Riess; Jeannette Hübener-Schmid
Journal:  Front Mol Neurosci       Date:  2018-10-10       Impact factor: 5.639

7.  PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study.

Authors:  Kathrin Gonsior; Gabriele Anna Kaucher; Patrik Pelz; Dorothea Schumann; Melanie Gansel; Sandra Kuhs; Thomas Klockgether; Sylvie Forlani; Alexandra Durr; Stefan Hauser; Tim W Rattay; Matthis Synofzik; Holger Hengel; Ludger Schöls; Olaf H Rieß; Jeannette Hübener-Schmid
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

Review 8.  Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.

Authors:  Bart P C van de Warrenburg; Hans van Bokhoven; Marina P Hommersom; Ronald A M Buijsen; Willeke M C van Roon-Mom
Journal:  Stem Cell Rev Rep       Date:  2021-05-25       Impact factor: 5.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.